Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- epirubicin
- Ophthocort (chloramphenicol / hydrocortisone / polymyxin b ophthalmic)
Interactions between your drugs
chloramphenicol ophthalmic epiRUBicin
Applies to: Ophthocort (chloramphenicol / hydrocortisone / polymyxin b ophthalmic), epirubicin
After using chloramphenicol ophthalmic, some of the medication may be absorbed into the bloodstream and may increase the risk of side effects that affect your bone marrow function, resulting in low numbers of different types of blood cells. Using chloramphenicol ophthalmic together with epiRUBicin may further increase those risks. You may be more likely to develop anemia, bleeding problems or infections due to low blood cell counts. Although serious side effects are not very common with medications administered to the eyes, ears, or vagina because only limited amounts of the medication generally get absorbed into the bloodstream, they can sometimes occur. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need more frequent monitoring to safely use both medications. You should seek medical attention if you develop paleness, fatigue, dizziness, fainting, unusual bruising or bleeding, fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Trazimera
Trazimera (trastuzumab-qyyp) is a biosimilar to Herceptin that may be used to treat certain types ...
Nolvadex
Nolvadex is used for breast cancer, breast cancer, adjuvant, breast cancer, male, breast cancer ...
Nerlynx
Nerlynx (neratinib) is used for the extended adjuvant treatment of early-stage, HER2-positive ...
Ogivri
Ogivri is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, esophageal ...
Ontruzant
Ontruzant is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, esophageal ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.